Ma Stacey 4

What Happened

• Stacey Ma, a non-employee director of Elanco Animal Health Inc. (ELAN), received equity awards on May 21, 2026: 4,678 deferred stock units (DSUs) and 12,196 restricted stock units (RSUs), each reported at $0.00 (no cash paid).
• Total units granted = 16,874. These were granted as part of routine board compensation (pro-rated annual director awards), not as an open-market purchase or sale.

Key Details

• Transaction date: May 21, 2026; Filing date (Form 4): May 26, 2026 — this filing was submitted after the typical two-business-day Form 4 deadline.
• Reported price: $0.00 for both grants (reflects awards, not a cash purchase).
• Shares/units granted: 4,678 (DSUs) and 12,196 (RSUs); combined 16,874 units.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 = pro-rated deferred stock units granted to non-employee board members; F2 = restricted stock units granted as the annual equity award to non-employee board members.
• Transaction code: A (award/grant).

Context

• RSUs are typically subject to vesting and convert to common shares upon vesting; DSUs are often deferred until tenure termination or a specified payout date — these awards are standard director compensation and do not necessarily signal insider opinion on the stock.
• Because this was an award (not a purchase or sale), it’s primarily compensation-related rather than a trading signal. The late filing may be worth noting for monitoring compliance but does not change the nature of the award.